Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses Frontline Options for multiple myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.

click here to download slides

We thank our supporters of this program:
Abbvie, AMGEN, Bristol-Myers Squibb Celgene Corporation, Janssen Oncology, Takeda Oncology

Previous Post
ASH 2017: Separating Hype from Hope About CAR T-Cell Therapy
Next Post
ASH 2017: Role of Autologous Stem Cell Transplant (ASCT)

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.